Skip to main content

Clinician Burnout Reduces Efficacy of Trauma-Focused Psychotherapy

Medically reviewed by Carmen Pope, BPharm. Last updated on April 23, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 23, 2024 -- Therapist burnout is associated with reduced effectiveness of trauma-focused psychotherapies, according to a study published online April 17 in JAMA Network Open.

Nina A. Sayer, Ph.D., from the Center for Care Delivery and Outcomes Research at the Minneapolis Veterans Affairs Health Care System, and colleagues evaluated the association between clinician burnout and the outcomes of patients receiving guideline-recommended trauma-focused psychotherapies for posttraumatic stress disorder (PTSD). The analysis included survey responses from 165 licensed therapists and 961 of their patients with available outcome data.

The researchers found that 35.2 percent of therapists reported burnout and 34 percent of patients met criterion for clinically meaningful improvement. Clinically meaningful improvement in PTSD symptoms occurred in 28.3 percent of patients seen by therapists who reported burnout versus 36.8 percent of patients seen by therapists without burnout. Lower odds of clinically meaningful improvement were seen for patients of therapists experiencing burnout (adjusted odds ratio, 0.63). These results persisted when adjusting for dropout or session spacing.

"In this prospective cohort study, therapist burnout was associated with reduced effectiveness of trauma-focused psychotherapies," the authors write. "Studying when and how burnout affects patient outcomes may inform workplace interventions."

One author reported receiving royalties from Guilford Press.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Allergy-Related Psychological Distress Common

TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.